Infectious Complications in Drug Addicts: Seven-Year Review of 269 Hospitalized Narcotics Abusers in Switzerland by Scheidegger, Claude & Zimmerli, Werner
REVIEWS OF INFECTIOUS DISEASES • VOL. II, NUMBER 3 • MAY-JUNE 1989
© 1989 by The University of Chicago. All rights reserved. 0162-0886/89/1103-0012$02.00
INTERNATIONAL NOTES
Infectious Complications in Drug Addicts: Seven-Year Review of
269 Hospitalized Narcotics Abusers in Switzerland
Claude Scheidegger and Werner Zimmerli From the Departments of Medicine and Research,
University Hospital, Basel, Switzerland
In a retrospective survey of patients hospitalized in the Department of Medicine of the
University Hospital, Basel, Switzerland, from 1980to 1986, we found 269 patients with
history of past or current drug abuse. The charts of these patients were analyzed for in-
fectious complications according to defined criteria. Heroin was the principal drug con-
sumed by 95010. In 127patients (47010) at least one infectious complication was diagnosed.
In 125(31010) of 404 admissions, the infectious problem was the main reason for hospital-
ization. Among the 269 patients, 217 infective episodes occurred. Pulmonary infections
were the most frequently occurring (52 episodes). There were 44 cases of viral hepatitis,
30 of human immunodeficiency virus infection, and 25 of minor genital infections. Bone
and joint infections and sepsis/endocarditis werediagnosed in seven cases each. The overall
mortality was 4.1070; however, only three of the 11 deaths were attributed to infections.
Intravenous drug addiction is complicated by a high morbidity because of infections that
were seldom lethal during the observed period.
Intravenous drug addicts are a population at risk for
infectious complications such as bacteremia, funge-
mia, endocarditis, pneumonia, arthritis, osteomye-
litis, septic thrombophlebitis, soft tissue infections,
venereal diseases, viral hepatitis, and infections with
the human immunodeficiency virus (HIV) [1-22].
Between the 1940s and the 1970s, several publica-
tions covered the whole spectrum of infections
[23-29], whereas in the recent literature, more atten-
tion has been given to single infections in narcotics
abusers [1-22]. The present report describes all in-
fectious complications among drug addicts that have
been diagnosed at the medical department of the
Basel University Hospital (Basel, Switzerland) be-
tween 1980 and 1986. The frequencies and etiolo-
gies of the particular infections are presented and
compared with those described in the literature.
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Patients and Methods
The medical department of the Basel University Hos-
pital is a 280-bed acute care facility. It is the major
provider of acute medical care for the estimated 1,000
drug addicts in Basel. Drug abusers appear in the
emergency room when they feel sick or occasionally
they are brought by the police in cases of intoxica-
tion in public. Some patients are referred from ad-
diction treatment facilities if they require hospital-
ization for acute disease. History and physical
examination are recorded by house staff.
Patients were enrolled in the present study if they
reported a history of drug abuse, presented with in-
toxication and miosis responding to naloxone, or had
opiate metabolites in urine samples. Individuals with
exclusively oral drug abuse other than opiates were
excluded from the study. The medical charts of all
patients defined as narcotics abusers and admitted
to the department of medicine from January 1980
to December 1986 were reviewed. Patients who were
seen on the emergency ward only (mainly for intoxi-
cation) were not included in this study.
Regarding the development of the human immu-
nodeficiency virus (HIV) epidemic in Basel, the years
before 1984are defined as the pre-HIV era, i.e., the
time before HIV-associated diseases were recognized,
and the years 1985-1986 as the post-HlV era. Drug
addicts suspected to have HIV infection have been
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tested for the presence of HIV antibodies since De-
cember 1985, and all drug addicts have been rou-
tinely tested since 1986.
Diagnosis of infection was established according
to uniform criteria. Pneumonia was defined by a typ-
ical pulmonary infiltrate seen on chest roentgeno-
gram and by the presence of purulent sputum. Aspi-
ration pneumonia was assumed when there was
radiologic evidence of infiltration and a history of
coma or bronchoscopic evidence for aspiration with
fever and leukocytosis.
Endocarditis was classified as definite, probable,
or possible, as suggested by Pelletier and Petersdorf
[30] and Von Reyn et al. [31]. According to this
scheme, cases of endocarditis classified as definite
are those that have been histopathologically con-
firmed. Probable cases have persistently positive
blood cultures and either a new regurgitant murmur
or predisposing heart disease with evidence of em-
bolization. Possible endocarditis is diagnosed in pa-
tients with persistently positive blood cultures and
either a predisposing heart disease or an embolic
phenomenon.
Bacterial arthritis or osteomyelitis was identified
in patients with positive cultures from synovial fluid
or bone and also in cases with a suggestive clinical
picture and cytologic or histologic evidence of puru-
lent inflammation or positive blood cultures. HIV
infection was classified according to the Centers for
Disease Control's definition [32]. Hepatic disease
was assumed to be viral in the presence of positive
hepatitis B surface antigen orhepatitis A IgM, histo-
logic evidence of active viral hepatitis, or pathologic
results of liver function tests and inflammatory signs
(fever, leukocytosis) without any other explanation
(such as alcoholic hepatitis).
An undefined bacterial infection was presumed
if there were at least four of the following clinical
or laboratory conditions: fever ~39.0°C, chills, leu-
kocytosis ~20,000/mm3 or leukopenia ~3,OOO/mm3,
band forms ~25 070, vacuoles and toxic granulation
of the granulocytes, and favorable response to an em-
piric course of antibiotics. Unclear transitory fever
«12 h) after intravenous drug application was clas-
sified as pyrogenic reaction.
Those cases not clearly defined by the above
criteria were separately reviewed by two investiga-
tors. Chronic infections that led to repeated hospitali-
zations (mainly chronic viral hepatitis and HIV in-
fection) were recorded as single episodes. Statistical
analysis was performed by Fisher's exact test.
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Results
A total of 51,794 admissions were recorded in the
Department of Medicine of the Basel University
Hospital during the seven-year period. Among these
patients, 269 narcotics addicts were admitted 404
times (0.78070 of all admissions). Among those, 255
(94.8%) were principally heroin addicts. Only 14pa-
tients (5.2%) consumed exclusively cocaine, metha-
done, intravenous barbiturates, or amphetamines.
Drugs had been injected intravenously by 262
(97.4070) of 269 patients. Only seven (2.6%) exclu-
sively used another route such as inhalation (four
cases), oral intake, or intramuscular or subcutane-
ous injection. Duration of addiction was not de-
scribed frequently enough to permit any conclusive
statement. The mean age for the 269 individuals was
26.4 y (range 15-83 y, median 21 y); 56.3% were male.
Two hundred thirty-six (87.6%) were of Swiss ori-
gin, 27 were Western European, three were Eastern
European, two were from North African countries,
and one was from the United States.
One hundred twenty-seven hospitalized patients
(47.2070) had at least one infectious complication. In
125 of the 404 admissions (30.9%), the infectious
problem was the exclusive or main cause of hospi-
talization, an increase from 26.4% in the pre-HIV
era to 41.6070 in the post-HIV era (P < .001). Other
reasons for admissions were heavy intoxication with
oral drugs (27.6%), heroin (16.6%), or alcohol
(4.0070); withdrawal reactions (5.4%); and various
other medical reasons (15.5070). Table 1 lists the types
of infections in our patients compared with others
from published series. Lower respiratory tract infec-
tions, viral hepatitis, HIV infection, and genital in-
fections were most commonly diagnosed. Three of
these infections were lethal.
Lower respiratorytract injection. Bacterial pneu-
monia was diagnosed in 43 patients. Aspiration was
the assumed cause in 21 of these. The etiologic agents
in 22 cases of alveolar pneumonia or bronchopneu-
monia were Streptococcus pneumoniae (sevencases),
Haemophilus influenzae (two), mixed aerobic and
anaerobic flora (two), and Staphylococcus aureus
and Streptococcus viridans (one each). The last two
patients had empyema; in nine patients the etiology
remained unclear. Two drug addicts with pneumo-
coccal pneumonia had an HIV infection (groups II
and IVA, respectively) as the underlying disease. One
patient with pneumococcal pneumonia died from
multiple organ failure due to heroin intoxication.
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Table 1. Types of infections among hospitalized drug addicts.
Present series Reference (23] Reference (29] Reference (35] (1972-1983)
(1980-1986) (1938-1947) (1971)
Group 1* Group nt
Diagnosis No. (%) No. (010) No. (%) No. (%) No. (%)
Lower respiratory tract infection 52 (24.0) 16 (9.5) 15 (53.5) 21 (18.3)
Viral hepatitis (acute and chronic) 44 (20.3) 61 (36.l)t 7 (25.0) 51 (44.3)
HIV infection (group II, III, or IV) 30 (13.8)
Minor genital infection 25 (11.5) 41 (24.3)§ 3 (2.6)
Thrombophlebitis or soft tissue infection 13 (6.0) 72 (58.5) 24 (47.7) 5 (4.3)
Undefined bacterial infection 11 (5.1)
Bone and joint infection 7 (3.2) 1 (3.6) 1 (0.9)
Venereal disease 7 (3.2) 19 (11.2) 1 (3.6) 5 (4.3)
Primary bacteremia, fungemia, and endocarditis 7 (3.2) 15 (12.2) 8 (4.7) 1 (3.6) 9 (7.8)
Pyrogen reaction 6 (2.8) 1 (3.6)
Enteritis due to Salmonella species 3 (1.4)
Acute nonbacterial gastroenteritis 2 (0.9)
Malaria 29 (23.6)
Tetanus 7 (5.7)
Undefined fever 2 (7.1) 11 (9.7)
Candidal endophthalmitis 5 (4.3)
Various conditions 10 (4.6)11 4 (3.5)
Total no. of episodes 217 123 169 28 115
Total no. of patients 269 365 200 492 191
Mortality due to infection (%) 3/269 (1.1) 10/365 (2.7) 0/200 (0) 1/492 (0.2) 2/191 (1.0)
* Patients admitted for intoxication.
t Patients admitted for other reasons.
t All patients with acute hepatitis.
§ All patients were female.
II Purulent tonsillitis, febrile dental infection, upper respiratory tract infection, enterocolitis (Shigella species), anorectal abscess in
Crohn's disease, urinary tract infection (Escherichia colt), catheter-relatedthrombophlebitis, nosocomialbacteremia (Enterobacter cloacae),
acute cytomegalovirus infection, acute Epstein-Barr virus infection (one each).
Four patients with fever and cough had purulent
bronchitis without pneumonia. Three HI V-infected
drug addicts had interstitial pneumonia with Pneu-
mocystis carinii (two) and cytomegalovirus (one). Ac-
tive tuberculosis was diagnosed in two patients. One
with tuberculous pleurisy had no HIV antibodies;
the other with cavitary tuberculosis was not tested.
Viral hepatitis. Of the patients with active viral
hepatitis, 25 had acute and 19had chronic infections.
Acute episodes were caused by hepatitis A virus
(three) or hepatitis B virus (18 cases), one of them
with o-agent superinfection. Four patients werepre-
sumed to have non-A, non-B hepatitis. Of the 19pa-
tients with chronic hepatitis, 16 were diagnosed by
liver biopsy. Histopathologic examination revealed
chronic aggressive hepatitis in nine and chronic per-
sistent hepatitis in seven drug addicts. In three pa-
tients clinically diagnosed as having chronic viral
hepatitis, no histologic confirmation was attempted
during the study period. One patient died from
progressivehepatic coma with underlying chronic ag-
gressive hepatitis.
HIV infection. We have tested for HIV antibod-
ies in our patients since December 1984. Among 62
drug addicts tested from December 1984to Decem-
ber 1986, 30 were positive for HIV antibodies. In
1986, when HIV antibody testing was performed in
all hospitalized drug addicts, 26 (49010) of 53 patients
were seropositive. Seroconversion could not be
documented during the study period. Asymptom-
atic HIV infection (group II) was diagnosed in 19
patients (63.3%) and lymphadenopathy (group III
and IV, respectively)in two (6.7%) and nine patients
(30%). Both individuals in group III and nine of 19
patients in group II suffered from infections not in-
dicative of AIDS, namely, bacterial pneumonia
(five), endocarditis (two), undefined bacterial infec-
tion (two), transient candidemia (one), and purulent
soft tissue infection (one). The nine patients of group
IV had interstitial pneumonia (three) oral thrush
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(six), constitutional symptoms (six), or herpes sim-
plex genitalis (one).
Genital infections and venereal disease. Minor
genital infections were found in 25 female patients.
The etiologic agents were Trichomonas (10), papil-
lomavirus (six), Candida species (four), herpes sim-
plex (three), and Gardnerella vaginalis (two). Three
of 59 tested patients had latent syphilis. Two women
suffered from etiologically undefined pelvic inflam-
matory disease, one case associated with an intra-
uterine device. Gardnerella epididymitis was found
in one man. Gonococcal sepsis was assumed in one
patient. She had fever, oligoarthritis, and typical cu-
taneous lesions. Gonococci could not be cultured;
however, the gonococcal complement-binding reac-
tion turned positive.
Thrombophlebitis and soft tissue infection.
Thrombophlebitis at an injection site was seen in six
individuals. One additional patient presented with
lymphangitis and phlegmonous infection of the left
forearm. In two heroin addicts, phlegmonous infec-
tion complicated a crush syndrome of the forearm
due to severe intoxication. Furunculosis was seen in
two patients. One individual developed disseminated
ulcerative S. aureus lesions unrelated to injection
sites. Finally, granuloma pyogenicum of a thumb oc-
curred in one patient.
Bone and joint infection. Spondylitis was diag-
nosed in three patients. In each biopsy material re-
vealed purulent inflammation and/or microbial
growth (S. aureus and Pseudomonas aeruginosa,
respectively). The S. aureus spondylitis (fifth and
sixth thoracic vertebrae) was complicated by a
paravertebral abscess and pleural empyema. Sternal
osteomyelitis caused by S. aureus was diagnosed
from a presternal collection. A heroin addict (pa-
tient no. 7, table 2) with endocarditis had arthritis
in multiple joints. S. aureus was isolated from blood
and the synovial fluid of his right knee. Enterobac-
ter cloacae was isolated in the blood culture of a
woman with unilateral acute sacroileitis. Finally,
purulent gonarthritis without bacterial growth in the
synovial fluid or several blood cultures was seen in
one patient.
Unclassified bacteremia, fungemia, and endo-
carditis. Table 2 summarizes the data of seven pa-
tients who each had several positive blood cultures
on admission. Five patients (nos. 1-3, 6, and 7) in-
jected heroin alone, two injected dissolved tablets
in addition. Patient no. 4 was diagnosed as having
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a possible endocarditis on the basis of two positive
blood cultures and a predisposing heart disease. Pa-
tient no. 6 was classified as "probable endocarditis"
because of persistently positive blood cultures and
a new regurgitant heart murmur. Patient no. 7 had
definite endocarditis; he presented with endocardi-
tis of the aortic valve, cutaneous embolic manifesta-
tions, septic arthritis of both knees and hips, and
right hemiparesis. Primary replacement of the af-
fected valve was not performed because of continual
drug abuse. Despite adequate antibiotic therapy and
supportive care, the disease progressed, and the pa-
tient died with progressive heart failure during a
desperate attempt at valve replacement. Autopsy
confirmed destructive endocarditis of the aortic
valve, with embolic manifestations in the skin, brain,
kidneys, and spleen. In addition to these seven pa-
tients, one individual who was on treatment with
cefoxitin and tobramycin for presumed aspiration
pneumonia developed signs of septicemia. Four of
five of his blood cultures were positive for E. cloa-
cae on the 11th day of hospitalization. This episode
was classified as nosocomial bacteremia and conse-
quently does not appear in table 2.
Discussion
This study represents a retrospective analysis of in-
fections in drug addicts. Diagnoses have been estab-
lished on the basis of data from the patients' charts
according to preset criteria. Several types of infec-
tions that are common in drug addicts may be un-
derrepresented in this study because patients with
venereal diseases, skin infections, or endophthalmi-
tis are generally not hospitalized in the medical
department.
The reasons for the increased risk of infections
in drug abusers are several: (1) people who inject
themselves are often carriers of S. aureus [33]; (2)
unsterile drugs are injected with dirty needles and
syringes; (3) dental hygiene is often poor; (4) bac-
terial clearance by the tracheobronchial system is de-
creased during intoxication; (5) cell-mediated immu-
nity may be impaired not only by HIV infection but
also by intravenous drug abuse itself [34]; and (6)
promiscuity and prostitution increase the risk of
transmitting numerous infective agents.
To our knowledge, three other series [23, 29, 35]
have shown similar results, although there are sub-
stantial differences in the study design. In these
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reports, diagnostic criteria are not stated. Further-
more, patients admitted to the hospital for only a
few hours for intoxication were included in Quadri
and Russi's study [35] but not in our study. In our
series 26070 of the patients were hospitalized for in-
fections during the pre-HIV era, a number similar
to the 28070 of Hussey and Katz [23] but lower than
the 58070 reported by White [29]. The frequency of
different infections in our series is compared with
published data in table 1. It is obvious that Hussey
and Katz [23] presented only selected cases. White
[29] found fewer respiratory tract infections but more
venereal and other genital infections, soft tissue in-
fections, and cases of hepatitis. The lower rate of
viral hepatitis in our series may be due to the hepa-
titis B vaccine campaigns since 1982and to our reluc-
tance to hospitalize patients with hepatitis. The fact
that our patients mostly injected drugs intravenously,
not subcutaneously, contributes to the lower rate of
soft tissue infections and the lack of tetanus cases
in our study, compared with older American series
[23,24,26,28]. The absence of tetanus cases in our
series may also be a consequence of regular tetanus
vaccine campaigns in Swiss school children.
Bronchopulmonary infections were the main
infectious complication in our study. Similarly,
Marantz et al. [10] diagnosed pneumonia in 38070 of
87 febrile episodes in 75 drug addicts. In contrast,
others reported many fewerpulmonary infections [9,
23,29]. The low incidence of aspiration pneumonia
(1070) in Jaffe and Koschmann's study [9] is particu-
larly unusual. Opportunistic pneumonias in AIDS
patients were only seen in the last year of our study.
The rate of hospitalizations for infection increased
from 26070 in the pre-HIV era to 42070 in the post-
HIVera. Bacterial pneumonia, which is more com-
mon in HIV-infected individuals, has contributed to
this rise. At our hospital the first case of AIDS was
diagnosed in late 1984.There is therefore a lag time
of about four years for AIDS cases, compared with
large cities such as San Francisco and New York [36].
This explains our low incidence of AIDS-related dis-
eases and, particularly, the lack of infections with
atypical mycobacteria that commonly appear late in
the evolution of HIV infection [37].
However the propagation of HIV infection among
drug addicts is much faster in Switzerland than in
the United States, with the exception of New York
City [38]. For instance, in San Francisco in 1985, only
10070 of the narcotics addicts were infected with HIV
[21, 22]. In contrast, in Switzerland 22070 of the ad-
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diets had already developed antibodies to HIV by
1982and 49070 by 1985 [18]. In our study four of nine
patients tested before 1986were positive for HIV an-
tibodies. This number is biased since only selected
cases were tested. However, in 1986,when each drug
addict was tested for HIV antibodies, the prevalence
of 49070 was representative. This high prevalence of
HIV infection is amazing, since there are no "shoot-
ing galleries" in Switzerland [39, 40]. However, the
frequency of HIV antibody may be explained by fre-
quent needle sharing among acquaintances before
1986, when needles and syringes were made freely
available. In other European countries, HIV infec-
tion is also prevalent in drug addicts [22, 41, 42].
Arthritis and osteomyelitis are classic but rare in-
fections in drug abusers. They are mainly caused by
S. aureus but also by gram-negative rods, such as
Pseudomonasaeruginosa and Serratia species, or by
fungi. The arthritis has an unexplained predilection
for syndesmoses such as the sacroiliac, sternoclavic-
ular articulation, or symphysis pubis [11-13].
Special diagnostic problems are encountered in
drug addicts with initially unexplained fever. Such
individuals should be hospitalized since a major in-
fection cannot be ruled out by history or by clinical
examination [10]. The following differential diagno-
sis should be considered: pyrogenic reaction, fever
as a symptom of drug withdrawal, occult focal in-
fection, HIV infection group IVA, and bacteremia
or fungemia with or without endocarditis.
In cases with positive blood cultures, the question
arises of whether endocarditis is present; it cannot
be proved by history or by clinical signs [6-8, 10].
In the present study the rate of occurrence of en-
docarditis was 0.7070 of all admissions. Others have
reported higher rates in unselected hospitalized
(3.9070-8.3070) [6, 8, 9] and febrile (13070) [10] drug
addicts.
S. aureus is the most common pathogen in intra-
venous drug abusers [2]. Methicillin-resistant strains
of S. aureusare rarely encountered in our hospital;
between 1980 and 1986 only 3.6070 of the S. aureus
blood isolates of all hospitalized patients were
methicillin resistant (unpublished data). In the pres-
ent study group, every isolate of S. aureuswas sen-
sitive to methicillin. This finding contrasts with
results from other centers where up to 42070 of the
isolates in drug addicts are methicillin resistant [2,
39]. This may be due to the fact that Swiss drug ad-
dicts do not use prophylactic antibiotics (unpub-
lished results from interviews), whereas in Detroit,
492
79 of 180 bacteremic narcotics abusers took antibi-
otics, mainly cephalosporins [2].
Microorganisms of low virulence, mainly from
skin flora, can cause bacteremia and endocarditis
without focal disease in intravenous drug addicts.
Therefore microorganisms such as Staphylococcus
epidermidis, Corynebacterium species [43], Bacillus
species [44], and Candida species [3-5] have to be
considered as relevant pathogens. In our study this
is exemplified by a case in which three of four blood
cultures yielded Propionibacterium acnes. Dissemi-
nated candidal infections have been increasingly rec-
ognized in intravenous drug abusers [3-5]. In our
series the patient with candidemia (no. 5, table 2)
did not receive antifungal treatment because the cul-
tural result was ignored. An uneventful follow-up to
seven months showed that this episode was appar-
ently self-limited. The most probable source of Can-
dida in such patients was recognized in the meantime.
Candida species may colonize lemons or lemon juice,
which is used to dissolve certain types of heroin [5].
Among our study patients, three died of infec-
tion - one with pneumococcal pneumonia after an
overdose, one with endogenous hepatic coma in
posthepatitis cirrhosis, and one with fatal cardiac
failure as a consequence of aortic endocarditis. Dur-
ing the study period eight others died from nonin-
fectious causes, mainly drug overdose.
In conclusion, the pattern of infections in Swiss
drug addicts is different from that in patients re-
ported in older American series [23-29]. Specifically,
the rate of soft tissue infections is much lower, and
cases of tetanus and malaria are completely absent
in the present study, whereas lower respiratory tract
infections are more frequent.
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